Harry P. Selker, MD, MSPH

“We help researchers from all backgrounds to develop new methods and translate discoveries into practice, break down the barriers that slow the process of determining the effectiveness of those methods, and work together to bring about change that improves human health.”

Harry P. Selker, MD, MSPH
Tufts CTSI Dean and Principal Investigator


Tufts CTSI was established in 2008 with a Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH). We are one of more than 50 institutions comprising the national CTSA Consortium, led by the National Center for Advancing Translational Sciences, part of NIH.

During our first award, we build a robust partnership of 39 organizations and developed a unique identity within the CTSA Consortium, with nationally recognized strengths in emergency medicine, large effectiveness trials, clinical trials methods innovations, and translational science education.

In 2013, we were recognized as a translational science leader by NIH when we were awarded a second CTSA. This major accomplishment allows us to continue to provide extensive services, resources, education, and mentorship to investigators across the partnership.

From bench to bedside, to clinical practice, to care delivery and public health, to public policy and beyond, Tufts CTSI is committed to fostering collaboration and innovation across the translational spectrum.

The Aims of our NIH CTSA Grant

Aim 1

Strengthen Tufts CTSI overall by:

  • Organizing and leading our partners in their commitment to a shared home for clinical and translational research
  • Expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative clinical and translational research across disciplines and institutions
  • Advancing the field of clinical and translational research through local and national leadership and development of novel methods
  • Providing innovative and targeted education and training across the spectrum of translational research, from bench to bedside (T1), bedside to practice (T2), practice to public health (T3), and practice to public policy (T4).

Aim 2

Operationalize and implement the clinical and translational research home and its infrastructure, services and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures.

Aim 3

Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research.

Aim 4

Develop and broaden the clinical and translational research workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health.